AGN
AGN

Algernon Pharmaceuticals Inc.

Associated Securities:
Status
Active
Issued & Outstanding21,940,779
Reserved for Issuance14,087,036
Currency
CSE Index

About

Algernon Pharmaceuticals Inc.

Listing Date
February 01, 2016

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.